Skytrofa (previously Lonapegsomatropin Ascendis Pharma) 유럽 연합 - 독일어 - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hormone und analoga der hypophyse und des hypothalamus - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

Ciprofloxacin Sandoz i.v. 200 mg/100 ml Infusionslösung 스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

ciprofloxacin sandoz i.v. 200 mg/100 ml infusionslösung

sandoz pharmaceuticals ag - ciprofloxacinum - infusionslösung - ciprofloxacinum 200 mg ut ciprofloxacini hydrochloridum, acidum lacticum, natrii chloridum, natrii hydroxidum ad ph, acidum hydrochloridum 25 per centum ad ph, aqua ad iniectabile, q.s. ad solutionem pro 100 ml corresp. natrium max. 406 mg. - infektionskrankheiten - synthetika

Ciprofloxacin Sandoz i.v. 400 mg/200 ml Infusionslösung 스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

ciprofloxacin sandoz i.v. 400 mg/200 ml infusionslösung

sandoz pharmaceuticals ag - ciprofloxacinum - infusionslösung - ciprofloxacinum 400 mg ut ciprofloxacini hydrochloridum, acidum lacticum, natrii chloridum, natrii hydroxidum ad ph, acidum hydrochloridum 25 per centum ad ph, aqua ad iniectabile, q.s. ad solutionem pro 200 ml corresp. natrium max. 805.7 mg. - infektionskrankheiten - synthetika

Ciprofloxacin Fresenius i.v. 100 mg / 50 ml Infusionslösung 스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

ciprofloxacin fresenius i.v. 100 mg / 50 ml infusionslösung

fresenius kabi (schweiz) ag - ciprofloxacinum - infusionslösung - ciprofloxacinum 100 mg, natrii chloridum, acidum sulfuricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 50 ml. - infektionskrankheiten - synthetika

Ciprofloxacin Fresenius i.v. 200 mg / 100 ml Infusionslösung 스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

ciprofloxacin fresenius i.v. 200 mg / 100 ml infusionslösung

fresenius kabi (schweiz) ag - ciprofloxacinum - infusionslösung - ciprofloxacinum 200 mg natrii chloridum, acidum sulfuricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 100 ml. - infektionskrankheiten - synthetika

Ciprofloxacin Fresenius i.v. 400 mg / 200 ml Infusionslösung 스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

ciprofloxacin fresenius i.v. 400 mg / 200 ml infusionslösung

fresenius kabi (schweiz) ag - ciprofloxacinum - infusionslösung - ciprofloxacinum 400 mg natrii chloridum, acidum sulfuricum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 200 ml. - infektionskrankheiten - synthetika

Partusisten intrapartal 독일 - 독일어 - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

partusisten intrapartal

hikma farmaceutica (portugal), s.a. (8007071) - fenoterolhydrobromid - konzentrat zur herstellung einer injektionslösung - teil 1 - konzentrat zur herstellung einer injektionslösung; fenoterolhydrobromid (06253) 0,025 milligramm

Cisplatin 0,5 mg/ml Lösung medac 독일 - 독일어 - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

cisplatin 0,5 mg/ml lösung medac

medac gesellschaft für klinische spezialpräparate m.b.h. (3083854) - cisplatin - infusionslösung - teil 1 - infusionslösung; cisplatin (15579) 0,5 milligramm

Phelinun 유럽 연합 - 독일어 - EMA (European Medicines Agency)

phelinun

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastische mittel - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Sevorane 독일 - 독일어 - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

sevorane

abbvie deutschland gmbh & co. kg - zweigniederlassung - (8146051) - sevofluran - flüssigkeit zur herstellung eines dampfs zur inhalation - sevofluran (26960) 100 milliliter